← Leaderboards
Michael Holmes
University Of Pennsylvania
$2,416,645
Attributed
$2,416,645
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $582.5K · FY2015–19$1M$750K$500K$250K$0
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$2,416,645 · 1
By mechanism
U19$2,416,645 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Pennsylvania
Same institution · by research overlap
- James L Riley$56,591,102
- Carl H. June$35,377,952
- Katharine June Bar$15,418,177
- Irwin M Chaiken$15,499,914
- Benhur Lee$26,036,912
Others in their field
Top investigators on “Cxcr4 Gene”
- Michael R. Farzan · Boston Children'S Hospital$13,927,882
- John F Dipersio · Washington University$13,157,037
- Bing Chen · Boston Children'S Hospital$11,946,442
- Olimpia Meucci · Drexel University$11,509,666
- Joseph G Sodroski · University Of Pennsylvania$10,758,714
- You-Yang Zhao · University Of Illinois At Chicago$9,510,112
Research focus
Cxcr4 GeneCytokineCostCxcl12 GeneAffectAntiviral AgentsCollaborationsAutologousBaseCoupledAntiretroviral TherapyBiologyCcr5 GeneCd4 Positive T LymphocytesAntiviral ResponseAmino AcidsCellsCell SurfaceChemokine ReceptorChemotaxisBeta-ChemokinesClinical ResearchClinical TrialsDesign
Grant awards (5)
C34-modified Coreceptors as Potent Trans-dominant Inhibitors of HIV-1 Entry$432,400
U19 · FY2019 · AI · contact PI
C34-modified Coreceptors as Potent Trans-dominant Inhibitors of HIV-1 Entry$462,847
U19 · FY2018 · AI · contact PI
C34-modified Coreceptors as Potent Trans-dominant Inhibitors of HIV-1 Entry$582,529
U19 · FY2017 · AI · contact PI
C34-modified Coreceptors as Potent Trans-dominant Inhibitors of HIV-1 Entry$467,759
U19 · FY2016 · AI · contact PI
C34-modified Coreceptors as Potent Trans-dominant Inhibitors of HIV-1 Entry$471,110
U19 · FY2015 · AI · contact PI